US 6329416
Combination regimens using 3,3-substituted indoline derivatives
expired A61KA61K31/57A61K45/06
Quick answer
US patent 6329416 (Combination regimens using 3,3-substituted indoline derivatives) held by Ligand Pharmaceuticals Incorporated expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/57, A61K45/06, A61P, A61P15/18